Mechanistic insight into genome stability pathways

对基因组稳定性途径的机制洞察

基本信息

  • 批准号:
    10763597
  • 负责人:
  • 金额:
    $ 19.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Genome integrity depends on a robust DNA replication program and the activity of replication-coupled repair pathways that operate during different phases of the cell cycle. My laboratory has had a longstanding interest in the causes and consequences of replication stress. Replication stress arises when lesions in the genome persist due to repair deficiencies or when components of the replication machinery are dysfunctional. Although disease- causing mutations in essential replication factors are rare, they can cause pleiotropic and severe disorders, such as immunodeficiency, cardiomyopathy, or growth defects. In recent years, we have investigated the molecular mechanism that underlies these rare diseases. We have identified compound heterozygous patient mutations in the replication factor minichromosome maintenance protein 10 (MCM10), and have modeled them in human somatic cell lines. Although these mutations cause relatively mild cellular replication defects, they pose significant problems to telomere maintenance. One caveat of the current cell models is that they are immortalized and express telomerase constitutively. To better understand the impact of replication defects in the context of cellular development of affected tissues, we propose to engineer genome-edited induced pluripotent stem cells and differentiate them into specific cell types in vitro. This presents a valuable alternative to animal models which, relevantly, do not fully mimic telomere homeostasis in humans. Moreover, we are interested in the pathways that cells activate for survival under conditions of mild replication stress. Previous work has identified a network based on ubiquitination and SUMOylation, and ring finger protein 4 (RNF4) as a key component. RNF4 is a SUMO- targeted E3 ubiquitin ligase that has been implicated in double-strand break repair, however, its role at replication forks and in telomere maintenance is not well understood. A genetic interaction screen has identified Bloom helicase (BLM), a RecQ-family helicase that causes premature aging, and ubiquitin specific peptidase 7 (USP7), a deubiquitinase, as strong negative interactors. Mutations in USP7 have been linked to rare neurodevelopmental disorders, but its cellular action has remained obscure. Interestingly, USP7 and BLM also regulate DNA replication and telomere length. We will investigate the relationship between RNF4, USP7 and BLM in chromosome inheritance in telomerase-positive and -negative cells. Lastly, a common feature of replication stress is under-replication due to an inability to duplicate the entire genome. As a result, single- stranded gaps persist that can either be filled by post-replicative repair that is regulated by the ubiquitination of PCNA or, as a last resort, by mitotic DNA synthesis (MiDAS). MiDAS is a break-induced replication (BIR)-like pathway that, unlike a classical replication fork, copies DNA by displacement synthesis. We will study how ubiquitinated PCNA controls MiDAS, and will determine whether other BIR-related pathways are regulated by PCNA ubiquitination. In summary, the questions addressed in this proposal will elucidate fundamental and disease-relevant mechanisms of genome stability pathways in human cells.
项目摘要 基因组完整性取决于强大的DNA复制程序和复制耦合修复的活性 在细胞周期的不同阶段运行的途径。我的实验室对 复制应力的原因和后果。当基因组中的病变持续存在时,会出现复制应力 由于修复缺陷或复制机械的组件功能失调时。虽然疾病 - 引起基本复制因子的突变很少见,它们会引起多效和严重疾病,例如 作为免疫缺陷,心肌病或生长缺陷。近年来,我们研究了分子 这些罕见疾病的基础的机制。我们已经确定了复合杂合子患者突变 复制因子微小颜色体维持蛋白10(MCM10),并在人类中进行了建模 体细胞系。尽管这些突变导致相对温和的细胞复制缺陷,但它们构成了 端粒维护的重大问题。当前细胞模型的一个警告是它们是永生的 并组成性地表达端粒酶。更好地理解复制缺陷的影响 细胞的生长受影响的组织的发展,我们建议设计基因组编辑的诱导多能干细胞 并将它们区分为体外特定细胞类型。这为动物模型提供了宝贵的替代品 相关,不要完全模仿人类的端粒稳态。而且,我们对 细胞在轻度复制应激条件下激活生存。以前的工作已经确定了基于网络的 在泛素化和sumoylation上,环手指蛋白4(RNF4)作为关键成分。 RNF4是相扑 靶向的E3泛素连接酶与双链断裂维修有关,但是,其在复制中的作用 叉子和端粒维护中尚不清楚。遗传相互作用屏幕已经确定了开花 解旋酶(BLM),一种导致过早衰老的RECQ家庭解旋酶,以及泛素特异性肽酶7(USP7),, 去泛素酶,作为强烈的负相互作用。 USP7中的突变与罕见 神经发育障碍,但其细胞作用仍然晦涩难懂。有趣的是,USP7和BLM也 调节DNA复制和端粒长度。我们将研究RNF4,USP7和 BLM在端粒酶阳性和阴性细胞中的染色体遗传中。最后,一个共同特征的 由于无法复制整个基因组,复制应力的复制不足。结果, 搁浅的差距持续存在,可以通过泛滥的修复后修复来填补。 PCNA或作为最后的手段,通过有丝分裂DNA合成(MIDAS)。 MIDAS是突破引起的复制(BIR) 与经典复制叉不同的途径通过位移合成复制DNA。我们将研究如何 泛素化的PCNA控制MIDAS,并将确定其他与BIR相关的途径是否受到调节 PCNA泛素化。总而言之,本提案中提出的问题将阐明基本和 人类细胞中基因组稳定途径相关的疾病机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anja-Katrin Bielinsky其他文献

Anja-Katrin Bielinsky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anja-Katrin Bielinsky', 18)}}的其他基金

Mechanism of radial chromosome formation in human premature aging syndrome cells
人类早衰综合征细胞放射状染色体形成机制
  • 批准号:
    10793247
  • 财政年份:
    2022
  • 资助金额:
    $ 19.18万
  • 项目类别:
Mechanism of radial chromosome formation in human premature aging syndrome cells
人类早衰综合征细胞放射状染色体形成机制
  • 批准号:
    10592123
  • 财政年份:
    2022
  • 资助金额:
    $ 19.18万
  • 项目类别:
Mechanistic insight into genome stability pathways
对基因组稳定性途径的机制洞察
  • 批准号:
    10205825
  • 财政年份:
    2021
  • 资助金额:
    $ 19.18万
  • 项目类别:
Mechanistic insight into genome stability pathways
对基因组稳定性途径的机制洞察
  • 批准号:
    10402940
  • 财政年份:
    2021
  • 资助金额:
    $ 19.18万
  • 项目类别:
Mechanistic insight into genome stability pathways
对基因组稳定性途径的机制洞察
  • 批准号:
    10624856
  • 财政年份:
    2021
  • 资助金额:
    $ 19.18万
  • 项目类别:
The role of DNA damage tolerance pathways in human cells
DNA损伤耐受途径在人类细胞中的作用
  • 批准号:
    10436922
  • 财政年份:
    2019
  • 资助金额:
    $ 19.18万
  • 项目类别:
The role of DNA damage tolerance pathways in human cells
DNA损伤耐受途径在人类细胞中的作用
  • 批准号:
    10170386
  • 财政年份:
    2019
  • 资助金额:
    $ 19.18万
  • 项目类别:
The role of DNA damage tolerance pathways in human cells
DNA损伤耐受途径在人类细胞中的作用
  • 批准号:
    10750291
  • 财政年份:
    2019
  • 资助金额:
    $ 19.18万
  • 项目类别:
Understanding the biological function of Mcm10 in yeast
了解 Mcm10 在酵母中的生物学功能
  • 批准号:
    8002867
  • 财政年份:
    2010
  • 资助金额:
    $ 19.18万
  • 项目类别:
Understanding the Biological Function of MCM 10
了解 MCM 10 的生物学功能
  • 批准号:
    8106727
  • 财政年份:
    2005
  • 资助金额:
    $ 19.18万
  • 项目类别:

相似国自然基金

儿童含糖饮料消费行为机制与干预策略研究:基于时间洞察力和跨理论模型的前瞻性平行对照试验
  • 批准号:
    82273748
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
基于Insight-HXMT开展伽玛射线暴时变和能谱的物理研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    40 万元
  • 项目类别:
    联合基金项目
Insight-HXMT对X射线暂现源的监测和高统计量定点观测研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    40 万元
  • 项目类别:
    联合基金项目
基于Insight-HXMT和Fermi-LAT对微类星体观测的联合分析研究
  • 批准号:
    U1938103
  • 批准年份:
    2019
  • 资助金额:
    50.0 万元
  • 项目类别:
    联合基金项目

相似海外基金

Mechanistic investigation into Frizzled-2 signaling for treatment of Osteogenesis Imperfecta
Frizzled-2 信号传导治疗成骨不全症的机制研究
  • 批准号:
    10680236
  • 财政年份:
    2023
  • 资助金额:
    $ 19.18万
  • 项目类别:
Mechanistic insights into multifaceted roles of coronavirus exoribonuclease complex
冠状病毒外核糖核酸酶复合物多方面作用的机制见解
  • 批准号:
    10713523
  • 财政年份:
    2023
  • 资助金额:
    $ 19.18万
  • 项目类别:
Mechanistic Insights into The Role of Microtubule Organizing Centers on Cardiomyocyte Structure and Function
微管组织中心对心肌细胞结构和功能作用的机制见解
  • 批准号:
    10743120
  • 财政年份:
    2023
  • 资助金额:
    $ 19.18万
  • 项目类别:
Mechanistic Insights into Catalytic Acyl C-O and C-N Activation and Cross Coupling
催化酰基 C-O 和 C-N 活化及交叉偶联的机理见解
  • 批准号:
    10713753
  • 财政年份:
    2023
  • 资助金额:
    $ 19.18万
  • 项目类别:
Mechanistic insights into LSD actions at 5-HT2A serotonin receptors
LSD 对 5-HT2A 血清素受体作用的机制见解
  • 批准号:
    10550420
  • 财政年份:
    2023
  • 资助金额:
    $ 19.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了